{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:01:58Z","timestamp":1794243718975,"version":"4.9.0"},"reference-count":241,"publisher":"Bentham Science Publishers Ltd.","issue":"16","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Fibrosis and pneumonitis are the most important side effects of lung tissue following cancer therapy. Radiotherapy and chemotherapy by some drugs, such as bleomycin, can induce pneumonitis and fibrosis. Targeted therapy and immunotherapy also may induce pneumonitis and fibrosis to a lesser extent compared to chemotherapy and radiotherapy. Activation of lymphocytes by immunotherapy or infiltration of inflammatory cells such as macrophages, lymphocytes, neutro-phils, and mast cells following chemo\/radiation therapy can induce pneumonitis. Furthermore, the polarization of macrophages toward M2 cells and the release of anti-inflammatory cytokines stimu-late fibrosis. Lung fibrosis and pneumonitis may also be potentiated by some other changes such as epithelial-mesenchymal transition (EMT), oxidative stress, reduction\/oxidation (redox) responses, renin-angiotensin system, and the upregulation of some inflammatory mediators such as a nuclear factor of kappa B (NF-\u03baB), inflammasome, cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS). Damages to the lung vascular system and the induction of hypoxia also can induce pulmonary injury following chemo\/radiation therapy. This review explains various mechanisms of the induction of pneumonitis and lung fibrosis following cancer therapy. Furthermore, the targets and promising agents to mitigate lung fibrosis and pneumonitis will be discussed.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389450123666220907144131","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:19:20Z","timestamp":1662722360000},"page":"1505-1525","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Lung Pneumonitis and Fibrosis in Cancer Therapy: A Review on Cellular and Molecular Mechanisms"],"prefix":"10.2174","volume":"23","author":[{"given":"Chaofeng","family":"Xu","sequence":"first","affiliation":[{"name":"Zhuji People\\'s Hospital of Zhejiang Province, Zhuji Affiliated Hospital of Shaoxing University, Zhuji, Zhejiang, 311800, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Najafi","sequence":"first","affiliation":[{"name":"Medical Technology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran"},{"name":"Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtu","family":"Shang","sequence":"additional","affiliation":[{"name":"Zhuji People\\'s Hospital of Zhejiang Province, Zhuji Affiliated Hospital of Shaoxing University, Zhuji, Zhejiang, 311800, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.radonc.2017.11.022","volume":"126","author":"Aznar M.C.","year":"2018","unstructured":"Aznar M.C.; Duane F.K.; Darby S.C.; Wang Z.; Taylor C.W.; Exposure of the lungs in breast cancer radiotherapy: A systematic review of lung doses published 2010-2015. Radiother Oncol 2018,126(1),148-154","journal-title":"Radiother Oncol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.21873\/anticanres.13773","volume":"39","author":"Nakao S.","year":"2019","unstructured":"Nakao S.; Yamaguchi K.; Sakamoto S.; Chemotherapy-associated acute exacerbation of interstitial lung disease shortens survival especially in small cell lung cancer. Anticancer Res 2019,39(10),5725-5731","journal-title":"Anticancer Res"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14737140.2018.1500180","volume":"18","author":"Li L.","year":"2018","unstructured":"Li L.; Mok H.; Jhaveri P.; Anticancer therapy and lung injury: Molecular mechanisms. Expert Rev Anticancer Ther 2018,18(10),1041-1057","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jtho.2020.02.005","volume":"15","author":"Goodman C.D.","year":"2020","unstructured":"Goodman C.D.; Nijman S.F.M.; Senan S.; A primer on interstitial lung disease and thoracic radiation. J Thorac Oncol 2020,15(6),902-913","journal-title":"J Thorac Oncol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.lungcan.2018.09.015","volume":"125","author":"Cho J.Y.","year":"2018","unstructured":"Cho J.Y.; Kim J.; Lee J.S.; Characteristics, incidence, and risk factors of immune checkpoint inhibitor-related pneumonitis in patients with non-small cell lung cancer. Lung Cancer 2018,125,150-156","journal-title":"Lung Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.4081\/monaldi.2018.917","volume":"88","author":"Bargagli E.","year":"2018","unstructured":"Bargagli E.; Bonti V.; Bindi A.; Fibrotic lung toxicity induced by cytotoxic drugs, radiation and immunotherapy in patients treated for lung cancer. Monaldi Arch Chest Dis 2018,88(2),917","journal-title":"Monaldi Arch Chest Dis"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clbc.2021.05.014","volume":"22","author":"Mo H.","year":"2022","unstructured":"Mo H.; Jazieh K.A.; Brinzevich D.; Abraham J.; A review of treatment-induced pulmonary toxicity in breast cancer: Pulmonary toxicity in breast cancer. Clinic Breast Can 2022,22(1),1-9","journal-title":"Clinic Breast Can"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","volume":"156","author":"Hanania A.N.","year":"2019","unstructured":"Hanania A.N.; Mainwaring W.; Ghebre Y.T.; Hanania N.A.; Ludwig M.; Radiation-induced lung injury: Assessment and management. Chest 2019,156(1),150-162","journal-title":"Chest"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3390\/ijms23094863","volume":"23","author":"Nguyen H.","year":"2022","unstructured":"Nguyen H.; Sangha S.; Pan M.; Oxidative stress and chemoradiation-induced oral mucositis: A scoping review of in vitro, in vivo and clinical studies. Int J Mol Sci 2022,23(9),4863","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12079-018-0473-3","volume":"13","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Goradel N.H.; Mortezaee K.; Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation. J Cell Commun Signal 2019,13(1),3-16","journal-title":"J Cell Commun Signal"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.3390\/ijms20061461","volume":"20","author":"Kinoshita T.","year":"2019","unstructured":"Kinoshita T.; Goto T.; Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: A review. Int J Mol Sci 2019,20(6),1461","journal-title":"Int J Mol Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000504968","volume":"99","author":"Mitropoulou G.","year":"2020","unstructured":"Mitropoulou G.; Daccord C.; Sauty A.; Immunotherapy-induced airway disease: A new pattern of lung toxicity of immune checkpoint inhibitors. Respiration 2020,99(2),181-186","journal-title":"Respiration"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","volume":"7","author":"Skeoch S.","year":"2018","unstructured":"Skeoch S.; Weatherley N.; Swift A.; Drug-induced interstitial lung disease: A systematic review. J Clin Med 2018,7(10),356","journal-title":"J Clin Med"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1111\/1759-7714.13967","volume":"12","author":"Li Y.","year":"2021","unstructured":"Li Y.; Zhou Y.; Liu Y.; Severe immune\u2010related hyperthermia followed by immune\u2010related pneumonitis with PD \u20101 inhibitor (sintilimab) in small cell lung cancer: A case report. Thorac Cancer 2021,12(11),1780-1783","journal-title":"Thorac Cancer"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/resp.13915","volume":"25","author":"Long K.","year":"2020","unstructured":"Long K.; Suresh K.; Pulmonary toxicity of systemic lung cancer therapy. Respirology 2020,25(S2)(Suppl. 2),72-79","journal-title":"Respirology"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00066-017-1257-z","volume":"194","author":"Vasiljevic D.","year":"2018","unstructured":"Vasiljevic D.; Arnold C.; Neuman D.; Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study. Strahlenther Onkol 2018,194(6),520-532","journal-title":"Strahlenther Onkol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/000348940911801111","volume":"118","author":"Purkey M.T.","year":"2009","unstructured":"Purkey M.T.; Levine M.S.; Prendes B.; Norman M.F.; Mirza N.; Predictors of aspiration pneumonia following radiotherapy for head and neck cancer. Ann Otol Rhinol Laryngol 2009,118(11),811-816","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.rpor.2020.03.023","volume":"25","author":"Ben Abdeljelil N.","year":"2020","unstructured":"Ben Abdeljelil N.; Ladeb S.; Dahmani T.; Once-a-day fractionated total-body irradiation: A regimen tailored to local logistics in allogeneic stem cell transplantation for acute lymphoblastic leukemia. Rep Pract Oncol Radiother 2020,25(3),436-441","journal-title":"Rep Pract Oncol Radiother"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12890-019-0905-8","volume":"19","author":"Yoo H.","year":"2019","unstructured":"Yoo H.; Jeong B-H.; Chung M.J.; Lee K.S.; Kwon O.J.; Chung M.P.; Risk factors and clinical characteristics of lung cancer in idiopathic pulmonary fibrosis: A retrospective cohort study. BMC Pulmon Med 2019,19(1),1-8","journal-title":"BMC Pulmon Med"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/RMI.S176901","volume":"13","author":"Frerker B.","year":"2020","unstructured":"Frerker B.; Hildebrandt G.; Distinguishing radiation pneumonitis from local tumour recurrence following SBRT for lung cancer. Reports in Medical Imaging 2020,13,1-23","journal-title":"Reports in Medical Imaging"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3332\/ecancer.2019.982","volume":"13","author":"Goossens M.E.","year":"2019","unstructured":"Goossens M.E.; Van den Bulcke M.; Gevaert T.; Is there any benefit to particles over photon radiotherapy? Ecancermedicalscience 2019,13,982","journal-title":"Ecancermedicalscience"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/cancers12061561","volume":"12","author":"Jin H.","year":"2020","unstructured":"Jin H.; Yoo Y.; Kim Y.; Kim Y.; Cho J.; Lee Y.S.; Radiation-induced lung fibrosis: Preclinical animal models and therapeutic strategies. Cancers (Basel) 2020,12(6),1561","journal-title":"Cancers (Basel)"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"5793","DOI":"10.21873\/anticanres.15396","volume":"41","author":"Fujiwara M.","year":"2021","unstructured":"Fujiwara M.; Doi H.; Igeta M.; Radiation pneumonitis after volumetric modulated arc therapy for non-small cell lung cancer. Anticancer Res 2021,41(11),5793-5802","journal-title":"Anticancer Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ijrobp.2020.03.028","volume":"107","author":"Griffin R.J.","year":"2020","unstructured":"Griffin R.J.; Ahmed M.M.; Amendola B.; Understanding high-dose, ultra-high dose rate, and spatially fractionated radiation therapy. Int J Radiat Oncol Biol Phys 2020,107(4),766-778","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.ijrobp.2018.12.010","volume":"103","author":"Ghita M.","year":"2019","unstructured":"Ghita M.; Dunne V.L.; McMahon S.J.; Preclinical evaluation of dose-volume effects and lung toxicity occurring in and out-of-field. Int J Radiat Oncol Biol Phys 2019,103(5),1231-1240","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/LCTT.S129833","volume":"9","author":"Donovan E.","year":"2018","unstructured":"Donovan E.; Swaminath A.; Stereotactic body radiation therapy (SBRT) in the management of non-small-cell lung cancer: Clinical impact and patient perspectives. Lung Cancer 2018,9,13-23","journal-title":"Lung Cancer"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.canlet.2012.01.007","volume":"332","author":"Roos W.P.","year":"2013","unstructured":"Roos W.P.; Kaina B.; DNA damage-induced cell death: From specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 2013,332(2),237-248","journal-title":"Cancer Lett"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3691","DOI":"10.1016\/j.molcel.2021.08.018","volume":"81","author":"Lennicke C.","year":"2021","unstructured":"Lennicke C.; Cochem\u00e9 H.M.; Redox metabolism: ROS as specific molecular regulators of cell signaling and function. Mol Cell 2021,81(18),3691-3707","journal-title":"Mol Cell"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"108952","DOI":"10.1016\/j.abb.2021.108952","volume":"708","author":"Fu X.","year":"2021","unstructured":"Fu X.; Tang J.; Wen P.; Huang Z.; Najafi M.; Redox interactions-induced cardiac toxicity in cancer therapy. Arch Biochem Biophys 2021,708,108952","journal-title":"Arch Biochem Biophys"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10495-021-01689-7","volume":"26","author":"Fu X.","year":"2021","unstructured":"Fu X.; Li M.; Tang C.; Huang Z.; Najafi M.; Targeting of cancer cell death mechanisms by resveratrol: A review. Apoptosis 2021,26(11-12),561-573","journal-title":"Apoptosis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2545","volume":"9","author":"Green D.R.","year":"2009","unstructured":"Green D.R.; Ferguson T.; Zitvogel L.; Kroemer G.; Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009,9(5),353-363","journal-title":"Nat Rev Immunol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s13277-010-0042-8","volume":"31","author":"Eriksson D.","year":"2010","unstructured":"Eriksson D.; Stigbrand T.; Radiation-induced cell death mechanisms. Tumour Biol 2010,31(4),363-372","journal-title":"Tumour Biol"},{"key":"ref=33","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-022-04502-4","author":"Wu X.","year":"2022","unstructured":"Wu X.; Xu W.W.; Huan X.; Mechanisms of cancer cell killing by metformin: A review on different cell death pathways. Mol Cell Biochem 2022","journal-title":"Mol Cell Biochem"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/wrr.12952","volume":"29","author":"Merkt W.","year":"2021","unstructured":"Merkt W.; Zhou Y.; Han H.; Lagares D.; Myofibroblast fate plasticity in tissue repair and fibrosis: De\u2010activation, apoptosis, senescence and reprogramming. Wound Rep Regenerat 2021,29(14),678-691","journal-title":"Wound Rep Regenerat"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.clinthera.2016.02.028","volume":"38","author":"Pandolfi F.","year":"2016","unstructured":"Pandolfi F.; Altamura S.; Frosali S.; Conti P.; Key role of DAMP in inflammation, cancer, and tissue repair. Clin Ther 2016,38(5),1017-1028","journal-title":"Clin Ther"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"106761","DOI":"10.1016\/j.intimp.2020.106761","volume":"86","author":"Ashrafizadeh M.","year":"2020","unstructured":"Ashrafizadeh M.; Farhood B.; Eleojo Musa A.; Taeb S.; Najafi M.; Damage-associated molecular patterns in tumor radiotherapy. Int Immunopharmacol 2020,86,106761","journal-title":"Int Immunopharmacol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1093\/jnci\/djt212","volume":"105","author":"Citrin D.E.","year":"2013","unstructured":"Citrin D.E.; Shankavaram U.; Horton J.A.; Role of type II pneumocyte senescence in radiation-induced lung fibrosis. J Natl Cancer Inst 2013,105(19),1474-1484","journal-title":"J Natl Cancer Inst"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-1-62703-239-1_10","author":"Rodier F.","year":"2013","unstructured":"Rodier F.; Detection of the Senescence-Associated Secretory Phenotype (SASP). Cell Senescence Methods in Molecular Biology 2013,165-173","journal-title":"Cell Senescence Methods in Molecular Biology"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/biof.1713","volume":"47","author":"Hosseini S.A.","year":"2021","unstructured":"Hosseini S.A.; Zahedipour F.; Sathyapalan T.; Jamialahmadi T.; Sahebkar A.; Pulmonary fibrosis: Therapeutic and mechanistic insights into the role of phytochemicals. Biofactors 2021,47(3),250-269","journal-title":"Biofactors"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1874467211666181010154709","volume":"12","author":"Mortezaee K.","year":"2019","unstructured":"Mortezaee K.; Goradel N.H.; Amini P.; NADPH oxidase as a target for modulation of radiation response; implications to carcinogenesis and radiotherapy. Curr Mol Pharmacol 2019,12(1),50-60","journal-title":"Curr Mol Pharmacol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bcp.2012.05.005","volume":"84","author":"Lee I.T.","year":"2012","unstructured":"Lee I.T.; Yang C.M.; Role of NADPH oxidase\/ROS in pro-inflammatory mediators-induced airway and pulmonary diseases. Biochem Pharmacol 2012,84(5),581-590","journal-title":"Biochem Pharmacol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41598-018-38414-5","volume":"9","author":"Tonison J.J.","year":"2019","unstructured":"Tonison J.J.; Fischer S.G.; Viehrig M.; Radiation pneumonitis after intensity-modulated radiotherapy for esophageal cancer: Institutional data and a systematic review. Sci Rep 2019,9(1),2255","journal-title":"Sci Rep"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/s41591-018-0090-y","volume":"24","author":"Anathy V.","year":"2018","unstructured":"Anathy V.; Lahue K.G.; Chapman D.G.; Reducing protein oxidation reverses lung fibrosis. Nat Med 2018,24(8),1128-1135","journal-title":"Nat Med"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"104745","DOI":"10.1016\/j.phrs.2020.104745","volume":"155","author":"Farhood B","year":"2020","unstructured":"Farhood B; khodamoradi E; Hoseini-Ghahfarokhi M; TGF-\u03b2 in radiotherapy: Mechanisms of tumor resistance and normal tissues injury. Pharmacol Res 2020,155,104745","journal-title":"Pharmacol Res"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"Yang H.","year":"2018","unstructured":"Yang H.; Villani R.M.; Wang H.; The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res 2018,37(1),1-10","journal-title":"J Exp Clin Cancer Res"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/jcm10040699","volume":"10","author":"Jeong B.K.","year":"2021","unstructured":"Jeong B.K.; Kim J.H.; Jung M.H.; Kang K.M.; Lee Y.H.; Cytokine profiles of non-small cell lung cancer patients treated with concurrent chemoradiotherapy with regards to radiation pneumonitis severity. J Clin Med 2021,10(4),699","journal-title":"J Clin Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"231ra247","DOI":"10.1126\/scitranslmed.3008182","volume":"6","author":"Hecker L.","year":"2014","unstructured":"Hecker L.; Logsdon N.J.; Kurundkar D.; Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med 2014,6(231),231ra247","journal-title":"Sci Transl Med"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12072-019-09967-y","volume":"13","author":"Wang L.","year":"2019","unstructured":"Wang L.; Wang F.S.; Clinical immunology and immunotherapy for hepatocellular carcinoma: Current progress and challenges. Hepatol Int 2019,13(5),521-533","journal-title":"Hepatol Int"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.lungcan.2016.06.025","volume":"99","author":"Semper H.","year":"2016","unstructured":"Semper H.; Muehlberg F.; Schulz-Menger J.; Allewelt M.; Groh\u00e9 C.; Drug-induced myocarditis after nivolumab treatment in a patient with PDL1- negative squamous cell carcinoma of the lung. Lung Cancer 2016,99,117-119","journal-title":"Lung Cancer"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40425-016-0117-1","volume":"4","author":"Koelzer V.H.","year":"2016","unstructured":"Koelzer V.H.; Rothschild S.I.; Zihler D.; Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study. J Immunother Cancer 2016,4(1),13","journal-title":"J Immunother Cancer"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-015-0105-x","volume":"4","author":"Heinzerling L.","year":"2016","unstructured":"Heinzerling L.; Ott P.A.; Hodi F.S.; Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy. J Immunoth Can 2016,4(1),1-11","journal-title":"J Immunoth Can"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s10637-010-9460-0","volume":"29","author":"Kim M.J.","year":"2011","unstructured":"Kim M.J.; Lee G.W.; Seo J.W.; Kim H.J.; Lim S.N.; Suh C.; Fatal interstitial pneumonitis in a patient with relapsed diffuse large B cell lymphoma following yttrium-90 ibritumomab tiuxetan. Invest New Drugs 2011,29(5),1098-1101","journal-title":"Invest New Drugs"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/cas.13979","volume":"110","author":"Sudo H.","year":"2019","unstructured":"Sudo H.; Tsuji A.B.; Sugyo A.; Therapeutic efficacy evaluation of radioimmunotherapy with 90 Y\u2010labeled anti\u2010podoplanin antibody NZ \u201012 for mesothelioma. Cancer Sci 2019,110(5),1653-1664","journal-title":"Cancer Sci"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1517\/14740338.2015.1085969","volume":"14","author":"Abdel-Rahman O.","year":"2015","unstructured":"Abdel-Rahman O.; ElHalawani H.; Fouad M.; Risk of elevated transaminases in cancer patients treated with immune checkpoint inhibitors: A meta-analysis. Expert Opin Drug Saf 2015,14(10),1507-1518","journal-title":"Expert Opin Drug Saf"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJMc1505197","volume":"373","author":"Nishino M.","year":"2015","unstructured":"Nishino M.; Sholl L.M.; Hatabu H.; Ramaiya N.H.; Hodi F.S.; Anti\u2013PD-1\u2013related pneumonitis during cancer immunotherapy. N Engl J Med 2015,373(3),288-290","journal-title":"N Engl J Med"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1093\/annonc\/mdv383","volume":"26","author":"Naidoo J.","year":"2015","unstructured":"Naidoo J.; Page D.B.; Li B.T.; Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. Ann Oncol 2015,26(12),2375-2391","journal-title":"Ann Oncol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1016\/S0140-6736(16)00587-0","volume":"387","author":"Fehrenbacher L.","year":"2016","unstructured":"Fehrenbacher L.; Spira A.; Ballinger M.; Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): A multicentre, open-label, phase 2 randomised controlled trial. Lancet 2016,387(10030),1837-1846","journal-title":"Lancet"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1378\/chest.12-1467","volume":"143","author":"Barjaktarevic I.Z.","year":"2013","unstructured":"Barjaktarevic I.Z.; Qadir N.; Suri A.; Santamauro J.T.; Stover D.; Organizing pneumonia as a side effect of ipilimumab treatment of melanoma. Chest 2013,143(3),858-861","journal-title":"Chest"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.3389\/fonc.2020.01785","volume":"10","author":"Zhu S.","year":"2020","unstructured":"Zhu S.; Fu Y.; Zhu B.; Zhang B.; Wang J.; Pneumonitis induced by immune checkpoint inhibitors: From clinical data to translational investigation. Front Oncol 2020,10,1785","journal-title":"Front Oncol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.21037\/tlcr.2019.05.02","volume":"8","author":"He Y.","year":"2019","unstructured":"He Y.; Zhou C.; Tyrosine kinase inhibitors interstitial pneumonitis: Diagnosis and management. Translat Lung Can Res 2019,8(Suppl. 3),S318-S320","journal-title":"Translat Lung Can Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jcma.2016.01.008","volume":"79","author":"Chiang C.L.","year":"2016","unstructured":"Chiang C.L.; Chen Y.W.; Wu M.H.; Huang H.C.; Tsai C.M.; Chiu C.H.; Radiation recall pneumonitis induced by epidermal growth factor receptor-tyrosine kinase inhibitor in patients with advanced nonsmall-cell lung cancer. J Chin Med Assoc 2016,79(5),248-255","journal-title":"J Chin Med Assoc"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s40264-016-0450-9","volume":"39","author":"Shah R.R.","year":"2016","unstructured":"Shah R.R.; Tyrosine kinase inhibitor-induced interstitial lung disease: Clinical features, diagnostic challenges, and therapeutic dilemmas. Drug Saf 2016,39(11),1073-1091","journal-title":"Drug Saf"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.bbrc.2019.06.127","volume":"516","author":"Chen Z.","year":"2019","unstructured":"Chen Z.; Yang H.; Li Z.; Xia Q.; Nie Y.; Temsirolimus as a dual inhibitor of retinoblastoma and angiogenesis via targeting mTOR signalling. Biochem Biophys Res Communicat 2019,516(3),726-732","journal-title":"Biochem Biophys Res Communicat"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"L1117","DOI":"10.1152\/ajplung.00251.2013","volume":"306","author":"Washino S.","year":"2014","unstructured":"Washino S.; Ando H.; Ushijima K.; Temsirolimus induces surfactant lipid accumulation and lung inflammation in mice. Am J Physiol Lung Cell Mol Physiol 2014,306(12),L1117-L1128","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/s41374-018-0158-9","volume":"99","author":"Kokuho N.","year":"2019","unstructured":"Kokuho N.; Terasaki Y.; Kunugi S.; Analyses of alveolar epithelial injury via lipid-related stress in mammalian target of rapamycin inhibitor-induced lung disease. Lab Invest 2019,99(6),853-865","journal-title":"Lab Invest"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tranon.2018.09.009","volume":"12","author":"Chen Z.","year":"2019","unstructured":"Chen Z.; Wu Z.; Ning W.; Advances in molecular mechanisms and treatment of radiation-induced pulmonary fibrosis. Transl Oncol 2019,12(1),162-169","journal-title":"Transl Oncol"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"697","DOI":"10.15171\/apb.2018.078","volume":"8","author":"Azmoonfar R.","year":"2018","unstructured":"Azmoonfar R.; Amini P.; Saffar H.; Metformin protects against radiation-induced pneumonitis and fibrosis and attenuates upregulation of dual oxidase genes expression. Adv Pharm Bull 2018,8(4),697-704","journal-title":"Adv Pharm Bull"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"39572","DOI":"10.1038\/srep39572","volume":"6","author":"Duru N.","year":"2016","unstructured":"Duru N.; Zhang Y.; Gernapudi R.; Loss of miR-140 is a key risk factor for radiation-induced lung fibrosis through reprogramming fibroblasts and macrophages. Sci Rep 2016,6(1),39572","journal-title":"Sci Rep"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1667\/RR14874.1","volume":"189","author":"Groves A.M.","year":"2018","unstructured":"Groves A.M.; Johnston C.J.; Williams J.P.; Finkelstein J.N.; Role of infiltrating monocytes in the development of radiation-induced pulmonary fibrosis. Radiat Res 2018,189(3),300-311","journal-title":"Radiat Res"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1800103","DOI":"10.1183\/13993003.00103-2018","volume":"51","author":"Zhou X.","year":"2018","unstructured":"Zhou X.; Moore B.B.; Location on origin? What is critical for macrophage propagation of lung fibrosis? Eur Respiratory Soc 2018,51(3),1800103","journal-title":"Eur Respiratory Soc"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.phrs.2021.105924","volume":"174","author":"Gupta D.","year":"2021","unstructured":"Gupta D.; Kumar A.; Mandloi A.; Shenoy V.; Renin angiotensin aldosterone system in pulmonary fibrosis: Pathogenesis to therapeutic possibilities. Pharmacol Res 2021,174,105924","journal-title":"Pharmacol Res"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/bcpt.13648","volume":"129","author":"Yu C.","year":"2021","unstructured":"Yu C.; Yang B.; Najafi M.; Targeting of cancer cell death mechanisms by curcumin: Implications to cancer therapy. Basic Clin Pharmacol Toxicol 2021,129(6),397-415","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13014-019-1228-x","volume":"14","author":"Furuse M.","year":"2019","unstructured":"Furuse M.; Nonoguchi N.; Yamada K.; Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: A systematic review. Radiat Oncol 2019,14(1),28","journal-title":"Radiat Oncol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jcb.27594","volume":"120","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Najafi M.; Salehi E.; Disruption of the redox balance with either oxidative or anti\u2010oxidative overloading as a promising target for cancer therapy. J Cell Biochem 2019,120(1),71-76","journal-title":"J Cell Biochem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/biof.1776","volume":"47","author":"Fu X.","year":"2021","unstructured":"Fu X.; He Y.; Li M.; Huang Z.; Najafi M.; Targeting of the tumor microenvironment by curcumin. Biofactors 2021,47(6),914-932","journal-title":"Biofactors"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10787-021-00894-9","volume":"30","author":"Yang R.","year":"2022","unstructured":"Yang R.; Tan C.; Najafi M.; Cardiac inflammation and fibrosis following chemo\/radiation therapy: Mechanisms and therapeutic agents. Inflammopharmacol 2022,30(1),73-89","journal-title":"Inflammopharmacol"},{"key":"ref=77","first-page":"4087298","volume":"2019","author":"Wu X.","year":"2019","unstructured":"Wu X.; Ji H.; Wang Y.; Melatonin alleviates radiation-induced lung injury via regulation of miR-30e\/NLRP3 axis. Oxid Med Cell Longev 2019,2019,4087298","journal-title":"Oxid Med Cell Longev"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3390\/medicina55080417","volume":"55","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Aliasgharzadeh A.; Amini P.; Mitigation of radiation-induced lung pneumonitis and fibrosis using metformin and melatonin: A histopathological study. Medicina (Kaunas) 2019,55(8),417","journal-title":"Medicina (Kaunas)"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2174\/1871523018666190319144020","volume":"19","author":"Azmoonfar R.","year":"2020","unstructured":"Azmoonfar R.; Amini P.; Yahyapour R.; Mitigation of radiation-induced pneumonitis and lung fibrosis using alpha-lipoic acid and resveratrol. Antiinflamm Antiallergy Agents Med Chem 2020,19(2),149-157","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2174\/2589977511666191018180758","volume":"11","author":"Yahyapour R.","year":"2019","unstructured":"Yahyapour R.; Amini P.; Saffar H.; Protective effect of metformin, resveratrol and alpha-lipoic acid on radiation-induced pneumonitis and fibrosis: A histopathological study. Curr Drug Res Rev 2019,11(2),111-117","journal-title":"Curr Drug Res Rev"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/09553002.2018.1446227","volume":"94","author":"Griffin F.","year":"2018","unstructured":"Griffin F.; Marignol L.; Therapeutic potential of melatonin for breast cancer radiation therapy patients. Int J Radiat Biol 2018,94(5),472-477","journal-title":"Int J Radiat Biol"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4103\/jcrt.JCRT_682_19","volume":"16","author":"Kahkesh M.H.","year":"2020","unstructured":"Kahkesh M.H.; Salehi Z.; Najafi M.; Ghobadi A.; Izad M.; Shirazi A.; The inhibitory effect of melatonin on the proliferation of irradiated A549 cell line. J Cancer Res Ther 2020,16(6),1500-1505","journal-title":"J Cancer Res Ther"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jpi.12205","volume":"58","year":"2015","unstructured":"Alonso\u2010Gonz\u00e1lez C, Gonz\u00e1lez A, Mart\u00ednez\u2010Campa C, G\u00f3mez\u2010Arozamena J, Cos S. Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double\u2010strand DNA break repair. J Pin Res 2015,58(2),189-197","journal-title":"J Pin Res"},{"key":"ref=84","first-page":"560","volume":"52","author":"Alonso-Gonz\u00e1lez C.","year":"2018","unstructured":"Alonso-Gonz\u00e1lez C.; Men\u00e9ndez-Men\u00e9ndez J.; Gonz\u00e1lez-Gonz\u00e1lez A.; Gonz\u00e1lez A.; Cos S.; Mart\u00ednez-Campa C.; Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF 7 human breast cancer cells. Int J Oncol 2018,52(2),560-570","journal-title":"Int J Oncol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"100763","DOI":"10.1016\/j.eclinm.2021.100763","volume":"33","author":"Seely D.","year":"2021","unstructured":"Seely D.; Legacy M.; Auer R.C.; Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial. EClinicalMedicine 2021,33,100763","journal-title":"EClinicalMedicine"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.2147\/OTT.S174100","volume":"11","author":"Wang Y.","year":"2018","unstructured":"Wang Y.; Wang P.; Zheng X.; Du X.; Therapeutic strategies of melatonin in cancer patients: A systematic review and meta-analysis. OncoTargets Ther 2018,11,7895-7908","journal-title":"OncoTargets Ther"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1574884714666181214101917","volume":"14","author":"Amini P.","year":"2019","unstructured":"Amini P.; Kolivand S.; Saffar H.; Protective effect of Selenium-L-methionine on radiation-induced acute pneumonitis and lung fibrosis in rat. Curr Clin Pharmacol 2019,14(2),157-164","journal-title":"Curr Clin Pharmacol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.3390\/ijms19103167","volume":"19","author":"Lobb R.","year":"2018","unstructured":"Lobb R.; Jacobson G.; Cursons R.; Jameson M.; The interaction of selenium with chemotherapy and radiation on normal and malignant human mononuclear blood cells. Int J Mol Sci 2018,19(10),3167","journal-title":"Int J Mol Sci"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2018.05.001","volume":"127","author":"Gandin V.","year":"2018","unstructured":"Gandin V.; Khalkar P.; Braude J.; Fernandes A.P.; Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment. Free Radic Biol Med 2018,127,80-97","journal-title":"Free Radic Biol Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"1907568","DOI":"10.1002\/adma.201907568","volume":"32","author":"Gao S.","year":"2020","unstructured":"Gao S.; Li T.; Guo Y.; Sun C.; Xianyu B.; Xu H.; Selenium\u2010containing nanoparticles combine the NK cells mediated immunotherapy with radiotherapy and chemotherapy. Adv Mater 2020,32(12),1907568","journal-title":"Adv Mater"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"598997","DOI":"10.3389\/fbioe.2020.598997","volume":"8","author":"Tian J.","year":"2020","unstructured":"Tian J.; Wei X.; Zhang W.; Xu A.; Effects of selenium nanoparticles combined with radiotherapy on lung cancer cells. Front Bioeng Biotechnol 2020,8,598997","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"18559","DOI":"10.1002\/jcb.29171","volume":"120","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Mortezaee K.; Motevaseli E.; Selenium as an adjuvant for modification of radiation response. J Cell Biochem 2019,120(11),18559-18571","journal-title":"J Cell Biochem"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00411-019-00801-5","volume":"58","author":"Schilling D.","year":"2019","unstructured":"Schilling D.; Herold B.; Combs S.E.; Schmid T.E.; Selenium does not affect radiosensitivity of breast cancer cell lines. Radiat Environ Biophys 2019,58(3),433-438","journal-title":"Radiat Environ Biophys"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"105802","DOI":"10.1016\/j.biocel.2020.105802","volume":"126","author":"Deng Z.","year":"2020","unstructured":"Deng Z.; Fear M.W.; Suk Choi Y.; The extracellular matrix and mechanotransduction in pulmonary fibrosis. Int J Biochem Cell Biol 2020,126,105802","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fonc.2019.00877","volume":"9","author":"Giuranno L.","year":"2019","unstructured":"Giuranno L.; Ient J.; De Ruysscher D.; Vooijs M.A.; Radiation-induced lung injury (RILI). Front Oncol 2019,9,877","journal-title":"Front Oncol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1080\/15569543.2020.1728337","volume":"40","author":"Moustafa E.M.","year":"2021","unstructured":"Moustafa E.M.; Ismail Ibrahim S.; Salem F.A.F.; Methylsulfonylmethane inhibits lung fibrosis progression, inflammatory response, and epithelial-mesenchymal transition via the transforming growth factor-\u03921\/SMAD2\/3 pathway in rats exposed to both \u03b3 -radiation and Bisphenol-A. Toxin Rev 2021,40(4),1431-1440","journal-title":"Toxin Rev"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.neo.2018.08.004","volume":"20","author":"Wang S.","year":"2018","unstructured":"Wang S.; Yan S.; Zhu S.; FOXF1 induces epithelial-mesenchymal transition in colorectal cancer metastasis by transcriptionally activating SNAI1. Neoplasia 2018,20(10),996-1007","journal-title":"Neoplasia"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/emboj.2012.336","volume":"32","author":"Balli D.","year":"2013","unstructured":"Balli D.; Ustiyan V.; Zhang Y.; Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition. EMBO J 2013,32(2),231-244","journal-title":"EMBO J"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1172\/JCI71104","volume":"124","author":"Xue J.","year":"2014","unstructured":"Xue J.; Lin X.; Chiu W.T.; Sustained activation of SMAD3\/SMAD4 by FOXM1 promotes TGF-\u03b2-dependent cancer metastasis. J Clin Invest 2014,124(2),564-579","journal-title":"J Clin Invest"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1111\/jcmm.13510","volume":"22","author":"Chen W.","year":"2018","unstructured":"Chen W.; Ren X.; Wu J.; HSP 27 associates with epithelial\u2013mesenchymal transition, stemness and radioresistance of salivary adenoid cystic carcinoma. J Cell Mol Med 2018,22(4),2283-2298","journal-title":"J Cell Mol Med"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3892\/ijmm.2016.2813","volume":"39","author":"Wang G.","year":"2017","unstructured":"Wang G.; Jiao H.; Zheng J.N.; Sun X.; HSP27 regulates TGF-\u03b2 mediated lung fibroblast differentiation through the Smad3 and ERK pathways. Int J Mol Med 2017,39(1),183-190","journal-title":"Int J Mol Med"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e0148998","DOI":"10.1371\/journal.pone.0148998","volume":"11","author":"Park A.M.","year":"2016","unstructured":"Park A.M.; Kanai K.; Itoh T.; Heat shock protein 27 plays a pivotal role in myofibroblast differentiation and in the development of bleomycin-induced pulmonary fibrosis. PLoS One 2016,11(2),e0148998","journal-title":"PLoS One"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.freeradbiomed.2011.11.024","volume":"52","author":"Nagarajan D.","year":"2012","unstructured":"Nagarajan D.; Melo T.; Deng Z.; Almeida C.; Zhao W.; ERK\/GSK3\u03b2\/Snail signaling mediates radiation-induced alveolar epithelial-to-mesenchymal transition. Free Radic Biol Med 2012,52(6),983-992","journal-title":"Free Radic Biol Med"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1158\/1078-0432.CCR-18-3900","volume":"25","author":"Kim J.Y.","year":"2019","unstructured":"Kim J.Y.; Jeon S.; Yoo Y.J.; The Hsp27-mediated IkB\u03b1-NF\u03baB signaling axis promotes radiation-induced lung fibrosis. Clin Cancer Res 2019,25(17),5364-5375","journal-title":"Clin Cancer Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/232791","volume":"2015","author":"Guo L.","year":"2015","unstructured":"Guo L.; Xu J.; Liu L.; Liu S.; Zhu R.; Hypoxia-induced epithelial-mesenchymal transition is involved in bleomycin-induced lung fibrosis. BioMed Res Int 2015,2015,1-10","journal-title":"BioMed Res Int"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"11018","DOI":"10.1111\/jcmm.15662","volume":"24","author":"Lei X.","year":"2020","unstructured":"Lei X.; Ma N.; Liang Y.; Glucosamine protects against radiation\u2010induced lung injury via inhibition of epithelial\u2010mesenchymal transition. J Cell Mol Med 2020,24(18),11018-11023","journal-title":"J Cell Mol Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1111\/jcmm.13230","volume":"21","author":"Cao K.","year":"2017","unstructured":"Cao K.; Lei X.; Liu H.; Polydatin alleviated radiation-induced lung injury through activation of Sirt3 and inhibition of epithelial-mesenchymal transition. J Cell Mol Med 2017,21(12),3264-3276","journal-title":"J Cell Mol Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/jcp.29138","volume":"235","author":"Gong L.","year":"2020","unstructured":"Gong L.; Wu X.; Li X.; S1PR3 deficiency alleviates radiation\u2010induced pulmonary fibrosis through the regulation of epithelial\u2013mesenchymal transition by targeting miR\u2010495\u20103p. J Cell Physiol 2020,235(3),2310-2324","journal-title":"J Cell Physiol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/jcp.29143","volume":"235","author":"Zhou J.","year":"2020","unstructured":"Zhou J.; Wu P.; Sun H.; Zhou H.; Zhang Y.; Xiao Z.; Lung tissue extracellular matrix\u2010derived hydrogels protect against radiation\u2010induced lung injury by suppressing epithelial-mesenchymal transition. J Cell Physiol 2020,235(3),2377-2388","journal-title":"J Cell Physiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1038\/s41598-019-41576-5","volume":"9","author":"Zhang Y.","year":"2019","unstructured":"Zhang Y.; Jiang X.; Ren L.; Optimization of the adipose-derived mesenchymal stem cell delivery time for radiation-induced lung fibrosis treatment in rats. Sci Rep 2019,9(1),5589","journal-title":"Sci Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0240-4","volume":"51","author":"Qu H.","year":"2019","unstructured":"Qu H.; Liu L.; Liu Z.; Blocking TBK1 alleviated radiation-induced pulmonary fibrosis and epithelial-mesenchymal transition through Akt-Erk inactivation. Exp Mol Med 2019,51(4),1-17","journal-title":"Exp Mol Med"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"117570","DOI":"10.1016\/j.lfs.2020.117570","volume":"250","author":"Farhood B","year":"2020","unstructured":"Farhood B; Ashrafizadeh M; khodamoradi E; Targeting of cellular redox metabolism for mitigation of radiation injury. Life Sci 2020,250,117570","journal-title":"Life Sci"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/mi.2013.103","volume":"7","author":"Li B","year":"2014","unstructured":"Li B; Alli R; Vogel P; Geiger TL; IL-10 modulates DSS-induced colitis through a macrophage\u2013ROS\u2013NO axis. Muc immunol 2014,7(4),869-878","journal-title":"Muc immunol"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fimmu.2014.00614","volume":"5","author":"Wang N.","year":"2014","unstructured":"Wang N.; Liang H.; Zen K.; Molecular mechanisms that influence the macrophage m1-m2 polarization balance. Front Immunol 2014,5,614","journal-title":"Front Immunol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"105795","DOI":"10.1016\/j.intimp.2019.105795","volume":"75","author":"Wang L.","year":"2019","unstructured":"Wang L.; Zhang Y.; Zhang N.; Xia J.; Zhan Q.; Wang C.; Potential role of M2 macrophage polarization in ventilator-induced lung fibrosis. Int Immunopharmacol 2019,75,105795","journal-title":"Int Immunopharmacol"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.21873\/invivo.11668","volume":"33","author":"Park H.R.","year":"2019","unstructured":"Park H.R.; Jo S.K.; Jung U.; Ionizing radiation promotes epithelial-to-Mesenchymal transition in lung epithelial cells by TGF-\u03b2-producing M2 macrophages. In Vivo 2019,33(6),1773-1784","journal-title":"In Vivo"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms14532","volume":"8","author":"Schafer MJ","year":"2017","unstructured":"Schafer MJ; White TA; Iijima K; Cellular senescence mediates fibrotic pulmonary disease. Nature communicat 2017,8(1),1-11","journal-title":"Nature communicat"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41419-021-03811-8","volume":"12","author":"Su L.","year":"2021","unstructured":"Su L.; Dong Y.; Wang Y.; Potential role of senescent macrophages in radiation-induced pulmonary fibrosis. Cell Death Dis 2021,12(6),527","journal-title":"Cell Death Dis"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1080\/09553002.2016.1222094","volume":"92","author":"Groves A.M.","year":"2016","unstructured":"Groves A.M.; Johnston C.J.; Misra R.S.; Williams J.P.; Finkelstein J.N.; Effects of IL-4 on pulmonary fibrosis and the accumulation and phenotype of macrophage subpopulations following thoracic irradiation. Int J Radiat Biol 2016,92(12),754-765","journal-title":"Int J Radiat Biol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"103180","DOI":"10.1016\/j.critrevonc.2020.103180","volume":"157","author":"Mortezaee K.","year":"2021","unstructured":"Mortezaee K.; Najafi M.; Immune system in cancer radiotherapy: Resistance mechanisms and therapy perspectives. Crit Rev Oncol Hematol 2021,157,103180","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e9342","DOI":"10.15252\/emmm.201809342","volume":"10","author":"Jones K.I.","year":"2018","unstructured":"Jones K.I.; Tiersma J.; Yuzhalin A.E.; Radiation combined with macrophage depletion promotes adaptive immunity and potentiates checkpoint blockade. EMBO Mol Med 2018,10(12),e9342","journal-title":"EMBO Mol Med"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/cells10020436","volume":"10","author":"Cheng P.","year":"2021","unstructured":"Cheng P.; Li S.; Chen H.; Macrophages in lung injury, repair, and fibrosis. Cells 2021,10(2),436","journal-title":"Cells"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"1702120","DOI":"10.1183\/13993003.02120-2017","volume":"51","author":"Meziani L.","year":"2018","unstructured":"Meziani L.; Mondini M.; Petit B.; CSF1R inhibition prevents radiation pulmonary fibrosis by depletion of interstitial macrophages. Eur Respirat J 2018,51(3),1702120","journal-title":"Eur Respirat J"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1667\/RR13831.1","volume":"184","author":"Yang S.","year":"2015","unstructured":"Yang S.; Zhang M.; Chen C.; Triptolide mitigates radiation-induced pulmonary fibrosis. Radiat Res 2015,184(5),509-517","journal-title":"Radiat Res"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"45133","DOI":"10.18632\/oncotarget.16456","volume":"8","author":"Chen C.","year":"2017","unstructured":"Chen C.; Yang S.; Zhang M.; Triptolide mitigates radiation-induced pneumonitis via inhibition of alveolar macrophages and related inflammatory molecules. Oncotarget 2017,8(28),45133-45142","journal-title":"Oncotarget"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15384047.2016.1139229","volume":"17","author":"Chen C.","year":"2016","unstructured":"Chen C.; Yang S.; Zhang M.; Triptolide mitigates radiation-induced pulmonary fibrosis via inhibition of axis of alveolar macrophages-NOXes-ROS-myofibroblasts. Cancer Biol Ther 2016,17(4),381-389","journal-title":"Cancer Biol Ther"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/bjh.16659","volume":"189","author":"Wan S.","year":"2020","unstructured":"Wan S.; Yi Q.; Fan S.; Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID\u201019) infected patients. Br J Haematol 2020,189(3),428-437","journal-title":"Br J Haematol"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12916-020-01718-3","volume":"18","author":"Teng F.","year":"2020","unstructured":"Teng F.; Li M.; Yu J.; Radiation recall pneumonitis induced by PD-1\/PD-L1 blockades: Mechanisms and therapeutic implications. BMC Med 2020,18(1),275","journal-title":"BMC Med"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fimmu.2016.00591","volume":"7","author":"Wirsd\u00f6rfer F.","year":"2016","unstructured":"Wirsd\u00f6rfer F.; Jendrossek V.; The role of lymphocytes in radiotherapy-induced adverse late effects in the lung. Front Immunol 2016,7,591-1","journal-title":"Front Immunol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1533033820951807","author":"Chen J.","year":"2020","unstructured":"Chen J.; Li X.; Huang C.; Lin Y.; Dai Q.; Change of serum inflammatory cytokines levels in patients with chronic obstructive pulmonary disease, pneumonia and lung cancer. Technol Cancer Res Treat 2020,19","journal-title":"Technol Cancer Res Treat"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"Yunna C.","year":"2020","unstructured":"Yunna C.; Mengru H.; Lei W.; Weidong C.; Macrophage M1\/M2 polarization. Eur J Pharmacol 2020,877,173090","journal-title":"Eur J Pharmacol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"585647","DOI":"10.3389\/fimmu.2020.585647","volume":"11","author":"Hu Z.J.","year":"2020","unstructured":"Hu Z.J.; Xu J.; Yin J.M.; Lower circulating interferon-gamma is a risk factor for lung fibrosis in COVID-19 patients. Front Immunol 2020,11,585647","journal-title":"Front Immunol"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s11010-019-03542-7","volume":"458","author":"Lee J.W.","year":"2019","unstructured":"Lee J.W.; Oh J.E.; Rhee K.J.; Co-treatment with interferon-\u03b3 and 1-methyl tryptophan ameliorates cardiac fibrosis through cardiac myofibroblasts apoptosis. Mol Cell Biochem 2019,458(1-2),197-205","journal-title":"Mol Cell Biochem"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbadis.2010.12.014","volume":"1822","author":"Theoharides T.C.","year":"2012","unstructured":"Theoharides T.C.; Alysandratos K.D.; Angelidou A.; Mast cells and inflammation. Biochim Biophys Acta Mol Basis Dis 2012,1822(1),21-33","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3389\/fphar.2013.00174","volume":"4","author":"Overed-Sayer C.","year":"2014","unstructured":"Overed-Sayer C.; Rapley L.; Mustelin T.; Clarke D.L.; Are mast cells instrumental for fibrotic diseases? Front Pharmacol 2014,4,174","journal-title":"Front Pharmacol"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ajpath.2010.10.003","volume":"178","author":"Blirando K.","year":"2011","unstructured":"Blirando K.; Milliat F.; Martelly I.; Sabourin J.C.; Benderitter M.; Fran\u00e7ois A.; Mast cells are an essential component of human radiation proctitis and contribute to experimental colorectal damage in mice. Am J Pathol 2011,178(2),640-651","journal-title":"Am J Pathol"},{"key":"ref=137","first-page":"236","volume":"21","author":"Akbar Aliasgharzadeh B.F.","year":"2019","unstructured":"Akbar Aliasgharzadeh B.F.; Amini P.; Saffar H.; Melatonin attenuates upregulation of Duox1 and Duox2 and protects against lung injury following rat\u2019s chest irradiation. Cell J 2019,21(3),236-242","journal-title":"Cell J"},{"key":"ref=138","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3390\/medicina55070317","volume":"55","author":"Farhood B.","year":"2019","unstructured":"Farhood B.; Aliasgharzadeh A.; Amini P.; Radiation-induced dual oxidase upregulation in rat heart tissues: Protective effect of melatonin. Medicina 2019,55(7),317","journal-title":"Medicina"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1689861","volume":"2019","author":"Soodaeva S.","year":"2019","unstructured":"Soodaeva S.; Kubysheva N.; Klimanov I.; Nikitina L.; Batyrshin I.; Features of oxidative and nitrosative metabolism in lung diseases. Oxid Med Cell Longev 2019,2019,1-12","journal-title":"Oxid Med Cell Longev"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"e435","DOI":"10.1016\/j.cllc.2020.02.025","volume":"21","author":"Naidoo J.","year":"2020","unstructured":"Naidoo J.; Nishino M.; Patel S.P.; Immune-related pneumonitis after chemoradiotherapy and subsequent immune checkpoint blockade in unresectable stage III non-small-cell lung cancer. Clin Lung Cancer 2020,21(5),e435-e444","journal-title":"Clin Lung Cancer"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00403-019-01972-3","volume":"312","author":"Nguyen J.K.","year":"2020","unstructured":"Nguyen J.K.; Austin E.; Huang A.; Mamalis A.; Jagdeo J.; The IL-4\/IL-13 axis in skin fibrosis and scarring: Mechanistic concepts and therapeutic targets. Arch Dermatol Res 2020,312(2),81-92","journal-title":"Arch Dermatol Res"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/toxsci\/kfu255","volume":"144","author":"Malaviya R.","year":"2015","unstructured":"Malaviya R.; Gow A.J.; Francis M.; Abramova E.V.; Laskin J.D.; Laskin D.L.; Radiation-induced lung injury and inflammation in mice: Role of inducible nitric oxide synthase and surfactant protein D. Toxicol Sci 2015,144(1),27-38","journal-title":"Toxicol Sci"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.yexcr.2017.11.019","volume":"362","author":"Li X.","year":"2018","unstructured":"Li X.; Guo L.; Liu Y.; MicroRNA-21 promotes wound healing via the Smad7-Smad2\/3-Elastin pathway. Exp Cell Res 2018,362(2),245-251","journal-title":"Exp Cell Res"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.pupt.2013.07.008","volume":"26","author":"Bei Y.","year":"2013","unstructured":"Bei Y.; Hua-Huy T.; Duong-Quy S.; Long-term treatment with fasudil improves bleomycin-induced pulmonary fibrosis and pulmonary hypertension via inhibition of Smad2\/3 phosphorylation. Pulm Pharmacol Ther 2013,26(6),635-643","journal-title":"Pulm Pharmacol Ther"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.3390\/jcm9051328","volume":"9","author":"Seccia T.M.","year":"2020","unstructured":"Seccia T.M.; Rigato M.; Ravarotto V.; Cal\u00f2 L.A.; ROCK (RhoA\/Rho Kinase) in cardiovascular\u2013renal pathophysiology: A review of new advancements. J Clin Med 2020,9(5),1328","journal-title":"J Clin Med"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"590972","DOI":"10.3389\/fphar.2020.590972","volume":"11","author":"Xie L.","year":"2020","unstructured":"Xie L.; Zeng Y.; Therapeutic potential of exosomes in pulmonary fibrosis. Front Pharmacol 2020,11,590972","journal-title":"Front Pharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.2174\/1389450111009011395","volume":"11","author":"Monceau V.","year":"2010","unstructured":"Monceau V.; Pasinetti N.; Schupp C.; Pouzoulet F.; Opolon P.; Vozenin M.C.; Modulation of the Rho\/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity. Curr Drug Targets 2010,11(11),1395-1404","journal-title":"Curr Drug Targets"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.3390\/ijms13078293","volume":"13","author":"Jiang C.","year":"2012","unstructured":"Jiang C.; Huang H.; Liu J.; Wang Y.; Lu Z.; Xu Z.; Fasudil, a Rho-kinase inhibitor, attenuates bleomycin-induced pulmonary fibrosis in mice. Int J Mol Sci 2012,13(7),8293-8307","journal-title":"Int J Mol Sci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.immuni.2021.04.021","volume":"54","author":"Buechler M.B.","year":"2021","unstructured":"Buechler M.B.; Fu W.; Turley S.J.; Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer. Immunity 2021,54(5),903-915","journal-title":"Immunity"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.bbadis.2013.01.022","volume":"1832","author":"Mackinnon A.","year":"2013","unstructured":"Mackinnon A.; Forbes S.; Bone marrow contributions to fibrosis. Biochim Biophys Acta Mol Basis Dis 2013,1832(7),955-961","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1165\/rcmb.2002-0069OC","volume":"29","author":"Epperly M.W.","year":"2003","unstructured":"Epperly M.W.; Guo H.; Gretton J.E.; Greenberger J.S.; Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis. Am J Respir Cell Mol Biol 2003,29(2),213-224","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=152","first-page":"31","volume":"22","author":"Liu Z.","year":"2018","unstructured":"Liu Z.; Lei X.; Li X.; Cai J.M.; Gao F.; Yang Y.Y.; Toll-like receptors and radiation protection. Eur Rev Med Pharmacol Sci 2018,22(1),31-39","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref=153","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2147\/OTT.S161109","volume":"11","author":"Xia L.","year":"2018","unstructured":"Xia L.; Tan S.; Zhou Y.; Role of the NF\u03baB-signaling pathway in cancer. OncoTarget Ther 2018,11,2063-2073","journal-title":"OncoTarget Ther"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"17187","DOI":"10.1002\/jcp.28504","volume":"234","author":"Mortezaee K","year":"2019","unstructured":"Mortezaee K; Najafi M; Farhood B; Ahmadi A; Shabeeb D; Musa AE.; NF\u2010\u03baB targeting for overcoming tumor resistance and normal tissues toxicity. J Cell Physiol 2019,234(10),17187-17204","journal-title":"J Cell Physiol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"130","DOI":"10.2174\/1568009619666191019143539","volume":"20","author":"Mortezaee K.","year":"2020","unstructured":"Mortezaee K.; Najafi M.; Farhood B.; Ahmadi A.; Shabeeb D.; Musa A.E.; Resveratrol as an adjuvant for normal tissues protection and tumor sensitization. Curr Cancer Drug Targets 2020,20(2),130-145","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"119721","DOI":"10.1016\/j.lfs.2021.119721","volume":"281","author":"Sheikholeslami S.","year":"2021","unstructured":"Sheikholeslami S.; Aryafar T.; Abedi-Firouzjah R.; The role of melatonin on radiation-induced pneumonitis and lung fibrosis: A systematic review. Life Sci 2021,281,119721","journal-title":"Life Sci"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41419-020-03178-2","volume":"11","author":"Peng L.","year":"2020","unstructured":"Peng L.; Wen L.; Shi Q.F.; Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-\u03baB\/NLRP3-mediated epithelial\u2013mesenchymal transition and inflammation. Cell Death Dis 2020,11(11),978","journal-title":"Cell Death Dis"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ijc.31907","volume":"144","author":"Wang R.","year":"2019","unstructured":"Wang R.; Peng S.; Zhang X.; Inhibition of NF-\u03baB improves sensitivity to irradiation and EGFR-TKIs and decreases irradiation-induced lung toxicity. Int J Cancer 2019,144(1),200-209","journal-title":"Int J Cancer"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1111\/1440-1681.13378","volume":"47","author":"Mansour H.H.","year":"2020","unstructured":"Mansour H.H.; Omran M.M.; Hasan H.F.; El kiki SM. Modulation of bleomycin\u2010induced oxidative stress and pulmonary fibrosis by N\u2010acetylcysteine in rats via AMPK\/SIRT1\/NF\u2010\u03ba\u03b2. Clin Exp Pharmacol Physiol 2020,47(12),1943-1952","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/jcmm.14703","volume":"24","author":"Zheng L.","year":"2020","unstructured":"Zheng L.; Zhu Q.; Xu C.; Glycyrrhizin mitigates radiation\u2010induced acute lung injury by inhibiting the HMGB1\/TLR4 signalling pathway. J Cell Mol Med 2020,24(1),214-226","journal-title":"J Cell Mol Med"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s10753-013-9789-6","volume":"37","author":"Seo K.","year":"2014","unstructured":"Seo K.; Yang J.H.; Kim S.C.; Ku S.K.; Ki S.H.; Shin S.M.; The antioxidant effects of isorhamnetin contribute to inhibit COX-2 expression in response to inflammation: A potential role of HO-1. Inflammation 2014,37(3),712-722","journal-title":"Inflammation"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.rvsc.2018.05.011","volume":"119","author":"Yang H.M.","year":"2018","unstructured":"Yang H.M.; Song W.J.; Li Q.; Canine mesenchymal stem cells treated with TNF-\u03b1 and IFN-\u03b3 enhance anti-inflammatory effects through the COX-2\/PGE2 pathway. Res Vet Sci 2018,119,19-26","journal-title":"Res Vet Sci"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.mehy.2011.04.002","volume":"77","author":"Luo C.","year":"2011","unstructured":"Luo C.; Urgard E.; Vooder T.; Metspalu A.; The role of COX-2 and Nrf2\/ARE in anti-inflammation and antioxidative stress: Aging and anti-aging. Med Hypotheses 2011,77(2),174-178","journal-title":"Med Hypotheses"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2174\/1874467211666180219102520","volume":"11","author":"Cheki M.","year":"2018","unstructured":"Cheki M.; Yahyapour R.; Farhood B.; COX-2 in radiotherapy: A potential target for radioprotection and radiosensitization. Curr Mol Pharmacol 2018,11(3),173-183","journal-title":"Curr Mol Pharmacol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2174\/1574885514666191119124739","volume":"15","author":"Azmoonfar R.","year":"2020","unstructured":"Azmoonfar R.; Amini P.; Saffar H.; Celecoxib a selective Cox-2 inhibitor mitigates fibrosis but not pneumonitis following lung irradiation: A histopathological study. Curr Drug Ther 2020,15(4),351-357","journal-title":"Curr Drug Ther"},{"key":"ref=166","first-page":"67","volume":"9","author":"Hegazy R.R.","year":"2010","unstructured":"Hegazy R.R.; El-Shaer M.A.; El-Batran S.A.; Sharaf O.A.; Knawy S.; The potential effect of capitopril celecoxib and their combination on experimentally rat model of lung fibrosis. IJIB 2010,9,67","journal-title":"IJIB"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ijrobp.2012.04.025","volume":"85","author":"Hunter N.R.","year":"2013","unstructured":"Hunter N.R.; Valdecanas D.; Liao Z.; Milas L.; Thames H.D.; Mason K.A.; Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib. Int J Radiat Oncol Biol Phys 2013,85(2),472-476","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.3390\/cancers12113276","volume":"12","author":"Giatromanolaki A.","year":"2020","unstructured":"Giatromanolaki A.; Tsolou A.; Daridou E.; Kouroupi M.; Chlichlia K.; Koukourakis M.I.; iNOS Expression by tumor-infiltrating lymphocytes, PD-L1 and prognosis in non-small-cell lung cancer. Cancers (Basel) 2020,12(11),3276","journal-title":"Cancers (Basel)"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0213-9626(08)70058-1","volume":"27","author":"Ibiza S.","year":"2008","unstructured":"Ibiza S.; Serrador J.M.; The role of nitric oxide in the regulation of adaptive immune responses. Inmunologia 2008,27(3),103-117","journal-title":"Inmunologia"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/gtc.12883","volume":"26","author":"Lv Y.","year":"2021","unstructured":"Lv Y.; Li Y.; Wang J.; MiR\u2010382\u20105p suppresses M1 macrophage polarization and inflammatory response in response to bronchopulmonary dysplasia through targeting CDK8: Involving inhibition of STAT1 pathway. Genes Cells 2021,26(10),772-781","journal-title":"Genes Cells"},{"key":"ref=171","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s00280-011-1654-4","volume":"67","author":"Singh S.","year":"2011","unstructured":"Singh S.; Gupta A.K.; Nitric oxide: Role in tumour biology and iNOS\/NO-based anticancer therapies. Can Chem Pharmacol 2011,67(6),1211-1224","journal-title":"Can Chem Pharmacol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.dnarep.2011.10.008","volume":"10","author":"Mutamba J.T.","year":"2011","unstructured":"Mutamba J.T.; Svilar D.; Prasongtanakij S.; XRCC1 and base excision repair balance in response to nitric oxide. DNA Repair (Amst) 2011,10(12),1282-1293","journal-title":"DNA Repair (Amst)"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.niox.2012.04.155","volume":"27","author":"Malik M.","year":"2012","unstructured":"Malik M.; Yuspa S.; iNOS-induced CLIC4 nuclear translocation regulates macrophage deactivation and TGF-\u03b2 signaling. Nitric Oxide 2012,27,S43","journal-title":"Nitric Oxide"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.niox.2017.07.005","volume":"70","author":"Chen C.","year":"2017","unstructured":"Chen C.; Yun X.J.; Liu L.; Guo H.; Liu L.F.; Chen X.L.; Exogenous nitric oxide enhances the prophylactic effect of aminoguanidine, a preferred iNOS inhibitor, on bleomycin-induced fibrosis in the lung: Implications for the direct roles of the NO molecule in vivo. Nitric Oxide 2017,70,31-41","journal-title":"Nitric Oxide"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3390\/ani9110951","volume":"9","author":"Saghir S.A.M.","year":"2019","unstructured":"Saghir S.A.M.; Al-Gabri N.A.; Khafaga A.F.; Thymoquinone-PLGA-PVA nanoparticles ameliorate bleomycin-induced pulmonary fibrosis in rats via regulation of inflammatory cytokines and iNOS signaling. Animals (Basel) 2019,9(11),951","journal-title":"Animals (Basel)"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.lfs.2008.03.018","volume":"82","author":"Kalayarasan S.","year":"2008","unstructured":"Kalayarasan S.; Sriram N.; Sudhandiran G.; Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-\u03baB, TNF-\u03b1 and IL-1\u03b2. Life Sci 2008,82(23-24),1142-1153","journal-title":"Life Sci"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"24476","DOI":"10.3390\/ijms141224476","volume":"14","author":"Zhu B.","year":"2013","unstructured":"Zhu B.; Ma A.Q.; Yang L.; Dang X.M.; Atorvastatin attenuates bleomycin-induced pulmonary fibrosis via suppressing iNOS expression and the CTGF (CCN2)\/ERK signaling pathway. Int J Mol Sci 2013,14(12),24476-24491","journal-title":"Int J Mol Sci"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1080\/01902148.2016.1244578","volume":"42","author":"Zaafan M.A.","year":"2016","unstructured":"Zaafan M.A.; Zaki H.F.; El-Brairy A.I.; Kenawy S.A.; Pyrrolidinedithiocarbamate attenuates bleomycin-induced pulmonary fibrosis in rats: Modulation of oxidative stress, fibrosis, and inflammatory parameters. Exp Lung Res 2016,42(8-10),408-416","journal-title":"Exp Lung Res"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3389\/fimmu.2017.00658","volume":"8","author":"Verma S.","year":"2017","unstructured":"Verma S.; Kalita B.; Bajaj S.; Prakash H.; Singh A.K.; Gupta M.L.; A combination of podophyllotoxin and rutin alleviates radiation-induced pneumonitis and fibrosis through modulation of lung inflammation in mice. Front Immunol 2017,8(658),658","journal-title":"Front Immunol"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fonc.2017.00007","volume":"7","author":"Abernathy L.M.","year":"2017","unstructured":"Abernathy L.M.; Fountain M.D.; Joiner M.C.; Hillman G.G.; Innate immune pathways associated with lung radioprotection by soy isoflavones. Front Oncol 2017,7(7),7","journal-title":"Front Oncol"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1007\/s00018-020-03479-x","volume":"77","author":"khodamoradi E","year":"2020","unstructured":"khodamoradi E; Hoseini-Ghahfarokhi M; Amini P; Targets for protection and mitigation of radiation injury. Cell Mol Life Sci 2020,77(16),3129-3159","journal-title":"Cell Mol Life Sci"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/jir.2013.0077","volume":"34","author":"Luan H.","year":"2014","unstructured":"Luan H.; Zhang Q.; Wang L.; OM85-BV induced the productions of IL-1\u03b2 IL-6, and TNF-\u03b1 via TLR4- and TLR2-mediated ERK1\/2\/NF-\u03baB pathway in RAW264.7 cells. J Interferon Cytokine Res 2014,34(7),526-536","journal-title":"J Interferon Cytokine Res"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.rmed.2013.12.007","volume":"108","author":"Go H.","year":"2014","unstructured":"Go H.; Koh J.; Kim H.S.; Jeon Y.K.; Chung D.H.; Expression of toll-like receptor 2 and 4 is increased in the respiratory epithelial cells of chronic idiopathic interstitial pneumonia patients. Respir Med 2014,108(5),783-792","journal-title":"Respir Med"},{"key":"ref=184","first-page":"976","volume":"45","author":"Liu H.","year":"2010","unstructured":"Liu H.; Yang H.; Mi S.; Cui B.; Hua F.; Hu Z.; Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice. Yao Xue Bao 2010,45(8),976-986","journal-title":"Yao Xue Bao"},{"key":"ref=185","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s00109-021-02113-y","volume":"99","author":"Bolourani S.","year":"2021","unstructured":"Bolourani S.; Brenner M.; Wang P.; The interplay of DAMPs, TLR4, and proinflammatory cytokines in pulmonary fibrosis. J Mol Med (Berl) 2021,99(10),1373-1384","journal-title":"J Mol Med (Berl)"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.4049\/jimmunol.1402377","volume":"194","author":"Ballinger M.N.","year":"2015","unstructured":"Ballinger M.N.; Newstead M.W.; Zeng X.; IRAK-M promotes alternative macrophage activation and fibroproliferation in bleomycin-induced lung injury. J Immunol 2015,194(4),1894-1904","journal-title":"J Immunol"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1164\/rccm.201108-1574OC","volume":"185","author":"Xu J.F.","year":"2012","unstructured":"Xu J.F.; Washko G.R.; Nakahira K.; Statins and pulmonary fibrosis: The potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med 2012,185(5),547-556","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/1753465815586335","volume":"9","author":"Hosseinian N.","year":"2015","unstructured":"Hosseinian N.; Cho Y.; Lockey R.F.; Kolliputi N.; The role of the NLRP3 inflammasome in pulmonary diseases. Ther Adv Respir Dis 2015,9(4),188-197","journal-title":"Ther Adv Respir Dis"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ni0311-199","volume":"12","author":"Kepp O.","year":"2011","unstructured":"Kepp O.; Galluzzi L.; Kroemer G.; Mitochondrial control of the NLRP3 inflammasome. Nat Immunol 2011,12(3),199-200","journal-title":"Nat Immunol"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"Swanson K.V.","year":"2019","unstructured":"Swanson K.V.; Deng M.; Ting J.P.Y.; The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat Rev Immunol 2019,19(8),477-489","journal-title":"Nat Rev Immunol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcell.2020.00140","volume":"8","author":"Huang S.","year":"2020","unstructured":"Huang S.; Che J.; Chu Q.; Zhang P.; The role of NLRP3 inflammasome in radiation-induced cardiovascular injury. Front Cell Dev Biol 2020,8,140","journal-title":"Front Cell Dev Biol"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s10571-018-0617-2","volume":"38","author":"Shang S.","year":"2018","unstructured":"Shang S.; Wang L.; Zhang Y.; Lu H.; Lu X.; The beta-hydroxybutyrate suppresses the migration of glioma cells by inhibition of NLRP3 inflammasome. Cell Mol Neurobiol 2018,38(8),1479-1489","journal-title":"Cell Mol Neurobiol"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ijrobp.2020.02.643","volume":"107","author":"Li X.","year":"2020","unstructured":"Li X.; Gong Y.; Li D.; Low-dose radiation therapy promotes radiation pneumonitis by activating NLRP3 inflammasome. Int J Radiat Oncol Biol Phys 2020,107(4),804-814","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.yexcr.2017.05.028","volume":"357","author":"Tian R.","year":"2017","unstructured":"Tian R.; Zhu Y.; Yao J.; NLRP3 participates in the regulation of EMT in bleomycin-induced pulmonary fibrosis. Exp Cell Res 2017,357(2),328-334","journal-title":"Exp Cell Res"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7574","volume":"6","author":"Dos Santos G.","year":"2015","unstructured":"Dos Santos G.; Rogel M.R.; Baker M.A.; Vimentin regulates activation of the NLRP3 inflammasome. Nat Communicat 2015,6(1),1-13","journal-title":"Nat Communicat"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41419-020-03335-7","volume":"12","author":"Noguchi T.","year":"2021","unstructured":"Noguchi T.; Sekiguchi Y.; Kudoh Y.; Gefitinib initiates sterile inflammation by promoting IL-1\u03b2 and HMGB1 release via two distinct mechanisms. Cell Death Dis 2021,12(1),49","journal-title":"Cell Death Dis"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.sbi.2019.03.001","volume":"59","author":"Magnani F.","year":"2019","unstructured":"Magnani F.; Mattevi A.; Structure and mechanisms of ROS generation by NADPH oxidases. Curr Opin Struct Biol 2019,59,91-97","journal-title":"Curr Opin Struct Biol"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/CS20140635","volume":"128","author":"Cachat J.","year":"2015","unstructured":"Cachat J.; Deffert C.; Hugues S.; Krause K.H.; Phagocyte NADPH oxidase and specific immunity. Clin Sci (Lond) 2015,128(10),635-648","journal-title":"Clin Sci (Lond)"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"9287","DOI":"10.1158\/0008-5472.CAN-10-2664","volume":"70","author":"Zhao Y.","year":"2010","unstructured":"Zhao Y.; McLaughlin D.; Robinson E.; Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy. Cancer Res 2010,70(22),9287-9297","journal-title":"Cancer Res"},{"key":"ref=200","doi-asserted-by":"publisher","first-page":"G1133","DOI":"10.1152\/ajpgi.00535.2011","volume":"302","author":"Yasuda M.","year":"2012","unstructured":"Yasuda M.; Kato S.; Yamanaka N.; Potential role of the NADPH oxidase NOX1 in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Am J Physiol Gastrointest Liver Physiol 2012,302(10),G1133-G1142","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=201","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00280-015-2716-9","volume":"75","author":"Ma W.","year":"2015","unstructured":"Ma W.; Hu J.; Cheng Y.; Wang J.; Zhang X.; Xu M.; Ginkgolide B protects against cisplatin-induced ototoxicity: Enhancement of Akt\u2013Nrf2\u2013HO-1 signaling and reduction of NADPH oxidase. Can Chem Pharmacol 2015,75(5),949-959","journal-title":"Can Chem Pharmacol"},{"key":"ref=202","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1667\/RR13799.1","volume":"183","author":"Weyemi U.","year":"2015","unstructured":"Weyemi U.; Redon C.E.; Aziz T.; Inactivation of NADPH oxidases NOX4 and NOX5 protects human primary fibroblasts from ionizing radiation-induced DNA damage. Radiat Res 2015,183(3),262-270","journal-title":"Radiat Res"},{"key":"ref=203","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00109-010-0622-5","volume":"88","author":"Park S.","year":"2010","unstructured":"Park S.; Ahn J.Y.; Lim M.J.; Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts. J Mol Med (Berl) 2010,88(8),807-816","journal-title":"J Mol Med (Berl)"},{"key":"ref=204","doi-asserted-by":"publisher","first-page":"108955","DOI":"10.1016\/j.biopha.2019.108955","volume":"115","author":"Yang Q.","year":"2019","unstructured":"Yang Q.; Zhang P.; Liu T.; Magnesium isoglycyrrhizinate ameliorates radiation-induced pulmonary fibrosis by inhibiting fibroblast differentiation via the p38MAPK\/Akt\/Nox4 pathway. Biomed Pharmacother 2019,115,108955","journal-title":"Biomed Pharmacother"},{"key":"ref=205","first-page":"236","volume":"21","author":"Aliasgharzadeh A.","year":"2019","unstructured":"Aliasgharzadeh A.; Farhood B.; Amini P.; Melatonin Attenuates Upregulation of Duox1 and Duox2 and Protects against Lung Injury following Chest Irradiation in Rats. Cell J 2019,21(3),236-242","journal-title":"Cell J"},{"key":"ref=206","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.intimp.2017.04.024","volume":"48","author":"Zhang D.","year":"2017","unstructured":"Zhang D.; Liu B.; Cao B.; Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-\u03b21\/Smad2 pathways and overexpression of NOX4. Int Immunopharmacol 2017,48,67-75","journal-title":"Int Immunopharmacol"},{"key":"ref=207","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","volume":"94","author":"Zorov D.B.","year":"2014","unstructured":"Zorov D.B.; Juhaszova M.; Sollott S.J.; Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014,94(3),909-950","journal-title":"Physiol Rev"},{"key":"ref=208","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.18632\/oncotarget.27958","volume":"12","author":"Kagi T.","year":"2021","unstructured":"Kagi T.; Noguchi T.; Matsuzawa A.; Mechanisms of gefitinib-induced interstitial pneumonitis: Why and how the TKI perturbs innate immune systems? Oncotarget 2021,12(13),1321-1322","journal-title":"Oncotarget"},{"key":"ref=209","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.3390\/cancers13194933","volume":"13","author":"Rossi F.","year":"2021","unstructured":"Rossi F.; Di Paola A.; Pota E.; Biological aspects of Inflamm-aging in childhood cancer survivors. Cancers (Basel) 2021,13(19),4933","journal-title":"Cancers (Basel)"},{"key":"ref=210","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cotox.2018.08.001","volume":"13","author":"Allawzi A.","year":"2019","unstructured":"Allawzi A.; Elajaili H.; Redente E.F.; Nozik-Grayck E.; Oxidative toxicology of bleomycin: Role of the extracellular redox environment. Curr Opin Toxicol 2019,13,68-73","journal-title":"Curr Opin Toxicol"},{"key":"ref=211","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13765-021-00646-x","volume":"64","author":"Ren C.X.","year":"2021","unstructured":"Ren C.X.; Jin X.; Xie D.P.; Hispidin attenuates bleomycin-induced idiopathic pulmonary fibrosis via an anti-oxidative effect in A549 cells. Appl Bio Chem 2021,64(1),74","journal-title":"Appl Bio Chem"},{"key":"ref=212","doi-asserted-by":"publisher","first-page":"e111882","DOI":"10.5812\/jjnpp.111882","volume":"16","author":"Raras T.Y.M.","year":"2021","unstructured":"Raras T.Y.M.; Hidayati N.; Wardhani S.O.; High doses of kefir accelerate lung-injury progression in bleomycin-induced pneumonitis in rats. Jundishapur J Nat Pharm Prod 2021,16(3),e111882","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"ref=213","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41598-017-00108-9","volume":"7","author":"Yang X.","year":"2017","unstructured":"Yang X.; Liu T.; Chen B.; Wang F.; Yang Q.; Chen X.; Grape seed proanthocyanidins prevent irradiation-induced differentiation of human lung fibroblasts by ameliorating mitochondrial dysfunction. Sci Rep 2017,7(1),62","journal-title":"Sci Rep"},{"key":"ref=214","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1007\/s10753-016-0419-y","volume":"39","author":"Zhang Q.","year":"2016","unstructured":"Zhang Q.; Hu Q.; Chu Y.; Xu B.; Song Q.; The influence of radiotherapy on AIM2 inflammasome in radiation pneumonitis. Inflammation 2016,39(5),1827-1834","journal-title":"Inflammation"},{"key":"ref=215","first-page":"212","volume":"7","author":"Amini P.","year":"2018","unstructured":"Amini P.; Saffar H.; Nourani M.R.; Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats. Int J Mol Cell Med 2018,7(4),212-219","journal-title":"Int J Mol Cell Med"},{"key":"ref=216","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1158\/1078-0432.CCR-18-0236","volume":"24","author":"Pinter M.","year":"2018","unstructured":"Pinter M.; Kwanten W.J.; Jain R.K.; Renin\u2013angiotensin system inhibitors to mitigate cancer treatment\u2013related adverse events. Clin Cancer Res 2018,24(16),3803-3812","journal-title":"Clin Cancer Res"},{"key":"ref=217","first-page":"e387","volume":"33","author":"Ara\u00fajo WF","year":"2015","unstructured":"Ara\u00fajo WF; Naves MA; Ravanini JN; Schor N; Teixeira VP; Elsevier 2015,33,e387-e389","journal-title":"Elsevier"},{"key":"ref=218","first-page":"884","volume":"11","author":"Yang J.","year":"2021","unstructured":"Yang J.; Yang X.; Gao L.; Zhang J.; Yi C.; Huang Y.; The role of the renin-angiotensin system inhibitors in malignancy: A review. Am J Cancer Res 2021,11(3),884-897","journal-title":"Am J Cancer Res"},{"key":"ref=219","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1159\/000337979","volume":"83","author":"Kim S.T.","year":"2012","unstructured":"Kim S.T.; Park K.H.; Oh S.C.; How does inhibition of the renin-angiotensin system affect the prognosis of advanced gastric cancer patients receiving platinum-based chemotherapy? Oncology 2012,83(6),354-360","journal-title":"Oncology"},{"key":"ref=220","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.ijrobp.2009.07.1743","volume":"75","author":"Ghosh S.N.","year":"2009","unstructured":"Ghosh S.N.; Zhang R.; Fish B.L.; Renin-Angiotensin system suppression mitigates experimental radiation pneumonitis. Int J Radiat Oncol Biol Phys 2009,75(5),1528-1536","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=221","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cllc.2015.08.007","volume":"17","author":"Bracci S.","year":"2016","unstructured":"Bracci S.; Valeriani M.; Agolli L.; De Sanctis V.; Maurizi Enrici R.; Osti M.F.; Renin-angiotensin system inhibitors might help to reduce the development of symptomatic radiation pneumonitis after stereotactic body radiotherapy for lung cancer. Clin Lung Cancer 2016,17(3),189-197","journal-title":"Clin Lung Cancer"},{"key":"ref=222","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijrobp.2011.11.013","volume":"84","author":"Kharofa J.","year":"2012","unstructured":"Kharofa J.; Cohen E.P.; Tomic R.; Xiang Q.; Gore E.; Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy. Int J Radiat Oncol Biol Phys 2012,84(1),238-243","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=223","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.ijrobp.2014.03.048","volume":"89","author":"Mahmood J.","year":"2014","unstructured":"Mahmood J.; Jelveh S.; Zaidi A.; Doctrow S.R.; Medhora M.; Hill R.P.; Targeting the Renin-angiotensin system combined with an antioxidant is highly effective in mitigating radiation-induced lung damage. Int J Radiat Oncol Biol Phys 2014,89(4),722-728","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref=224","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.2353\/ajpath.2010.081127","volume":"177","author":"Li P.","year":"2010","unstructured":"Li P.; Xiao H.D.; Xu J.; Angiotensin-converting enzyme N-terminal inactivation alleviates bleomycin-induced lung injury. Am J Pathol 2010,177(3),1113-1121","journal-title":"Am J Pathol"},{"key":"ref=225","doi-asserted-by":"publisher","first-page":"16525","DOI":"10.1038\/s41598-021-96152-7","volume":"11","author":"Chang J.","year":"2021","unstructured":"Chang J.; Nie H.; Ge X.; Vitamin D suppresses bleomycin-induced pulmonary fibrosis by targeting the local renin\u2013angiotensin system in the lung. Sci Rep 2021,11(1),16525","journal-title":"Sci Rep"},{"key":"ref=226","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00408-018-0103-0","volume":"196","author":"Liu X.","year":"2018","unstructured":"Liu X.; Khadtare N.; Patel H.; Stephani R.; Cantor J.; transient blockade of endothelin-1 mitigates amiodarone-induced pulmonary fibrosis. Lung 2018,196(3),321-327","journal-title":"Lung"},{"key":"ref=227","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000481201","volume":"95","author":"Manitsopoulos N.","year":"2018","unstructured":"Manitsopoulos N.; Nikitopoulou I.; Maniatis N.A.; Magkou C.; Kotanidou A.; Orfanos S.E.; Highly selective endothelin-1 receptor A inhibition prevents bleomycin-induced pulmonary inflammation and fibrosis in mice. Respiration 2018,95(2),122-136","journal-title":"Respiration"},{"key":"ref=228","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.33549\/physiolres.933812","volume":"67","author":"Hartopo A.B.","year":"2018","unstructured":"Hartopo A.B.; Arfian N.; Nakayama K.; Suzuki Y.; Yagi K.; Emoto N.; Endothelial-derived endothelin-1 promotes pulmonary vascular remodeling in bleomycin-induced pulmonary fibrosis. Physiol Res 2018,67(Suppl. 1),S185-S197","journal-title":"Physiol Res"},{"key":"ref=229","doi-asserted-by":"publisher","first-page":"23200","DOI":"10.1038\/srep23200","volume":"6","author":"You D.G.","year":"2016","unstructured":"You D.G.; Deepagan V.G.; Um W.; ROS-generating TiO2 nanoparticles for non-invasive sonodynamic therapy of cancer. Sci Rep 2016,6(1),23200","journal-title":"Sci Rep"},{"key":"ref=230","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","volume":"52","author":"Perillo B.","year":"2020","unstructured":"Perillo B.; Di Donato M.; Pezone A.; ROS in cancer therapy: The bright side of the moon. Exp Mol Med 2020,52(2),192-203","journal-title":"Exp Mol Med"},{"key":"ref=231","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12989-016-0133-9","volume":"13","author":"Guo H.","year":"2015","unstructured":"Guo H.; Zhang J.; Boudreau M.; Intravenous administration of silver nanoparticles causes organ toxicity through intracellular ROS-related loss of inter-endothelial junction. Part Fibre Toxicol 2015,13(1),21","journal-title":"Part Fibre Toxicol"},{"key":"ref=232","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.2174\/138161212802083716","volume":"18","author":"Paola Rosanna D.","year":"2012","unstructured":"Paola Rosanna D.; Salvatore C.; Reactive oxygen species, inflammation, and lung diseases. Curr Pharm Des 2012,18(26),3889-3900","journal-title":"Curr Pharm Des"},{"key":"ref=233","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-319-63245-2_8","author":"Kellner M.","year":"2017","unstructured":"Kellner M.; Noonepalle S.; Lu Q.; Srivastava A.; Zemskov E.; Black S.M.; Pulmonary vasculature redox signaling in health and disease 2017,105-137","journal-title":"Pulmonary vasculature redox signaling in health and disease"},{"key":"ref=234","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacbts.2018.01.014","volume":"3","author":"Venkatesulu B.P.","year":"2018","unstructured":"Venkatesulu B.P.; Mahadevan L.S.; Aliru M.L.; Radiation-induced endothelial vascular injury. JACC Basic Transl Sci 2018,3(4),563-572","journal-title":"JACC Basic Transl Sci"},{"key":"ref=235","doi-asserted-by":"publisher","first-page":"39501","DOI":"10.1038\/srep39501","volume":"7","author":"Khan S.Y.","year":"2017","unstructured":"Khan S.Y.; Awad E.M.; Oszwald A.; Premature senescence of endothelial cells upon chronic exposure to TNF\u03b1 can be prevented by N-acetyl cysteine and plumericin. Sci Rep 2017,7(1),39501","journal-title":"Sci Rep"},{"key":"ref=236","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.radonc.2021.02.007","volume":"158","author":"Wijerathne H.","year":"2021","unstructured":"Wijerathne H.; Langston J.C.; Yang Q.; Mechanisms of radiation-induced endothelium damage: Emerging models and technologies. Radiother Oncol 2021,158,21-32","journal-title":"Radiother Oncol"},{"key":"ref=237","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3389\/fimmu.2018.01667","volume":"9","author":"Wu G.","year":"2018","unstructured":"Wu G.; Xu G.; Chen D.W.; Hypoxia exacerbates inflammatory acute lung injury via the toll-like receptor 4 signaling pathway. Front Immunol 2018,9,1667","journal-title":"Front Immunol"},{"key":"ref=238","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-14-3193","volume":"21","author":"Choi S.H.","year":"2015","unstructured":"Choi S.H.; Hong Z.Y.; Nam J.K.; A hypoxia-induced vascular endothelial-to-mesenchymal transition in development of radiation-induced pulmonary fibrosis. Clin Cancer Res 2015,21(16),3716-3726","journal-title":"Clin Cancer Res"},{"key":"ref=239","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1667\/RR1816.1","volume":"173","author":"Rabbani Z.N.","year":"2010","unstructured":"Rabbani Z.N.; Mi J.; Zhang Y.; Hypoxia inducible factor 1alpha signaling in fractionated radiation-induced lung injury: Role of oxidative stress and tissue hypoxia. Radiat Res 2010,173(2),165-174","journal-title":"Radiat Res"},{"key":"ref=240","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.freeradbiomed.2012.04.014","volume":"53","author":"Jackson I.L.","year":"2012","unstructured":"Jackson I.L.; Zhang X.; Hadley C.; Temporal expression of hypoxia-regulated genes is associated with early changes in redox status in irradiated lung. Free Radic Biol Med 2012,53(2),337-346","journal-title":"Free Radic Biol Med"},{"key":"ref=241","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/10715760600913150","volume":"41","author":"Jackson I.L.","year":"2007","unstructured":"Jackson I.L.; Chen L.; Batinic-Haberle I.; Vujaskovic Z.; Superoxide dismutase mimetic reduces hypoxia-induced, TGF-\u03b2 and VEGF production by macrophages. Free Rad Res 2007,41(1),8-14","journal-title":"Free Rad Res"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220907144131","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208613\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220907144131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T19:42:04Z","timestamp":1701027724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208613\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":241,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220907144131","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-05","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}